1 / 7

Meningococcal Vaccines Industry Attractiveness, Competitive Landscape, PESTLE Analysis | Forecast – 2025

Meningococcal Vaccines Industry Research Report Analysis by Market Research Future (MRFR). The global market supply of vaccine doses was USD 172 Million in 2019 which is expected to reach USD 203 Million by 2025. The Market segmented on the basis of treatment, end user, and region - forecast till 2025.

ketshubhra
Download Presentation

Meningococcal Vaccines Industry Attractiveness, Competitive Landscape, PESTLE Analysis | Forecast – 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Meningococcal Vaccines Market Global Industry Analysis, Size Estimation, Share Analysis, Demand | Forecast to 2025 PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Meningococcal Vaccines Market Meningococcal Vaccines Market – Overview Global meningococcal vaccines market has a demand for about USD 172 million doses in 2019, while the estimated supply is likely to be 203 million doses. Meningococcal vaccines are vaccines used for preventing infection caused by Neisseria meningitidis. Subcapsular vaccine, polysaccharide, and meningococcal conjugate vaccine are the different types of vaccines effective against all or some of these meningococcus types- A, B, C, Y, and W-135. Various factors are adding to the global meningococcal vaccines market share. These factors, as per the new MRFR report, include a rise in healthcare spending, an increase in research and development for these vaccines, growing interventions by the government associated with meningococcal vaccines, presence of different government awareness programs, and manufacturing of meningococcal vaccines at budget-friendly prices. Additional factors adding market growth include various private public partnerships to carry out R&D activities, presence of meningococcal vaccines in the pipeline along with their expected commercialization, and rising prevalence of the disease. On the contrary, strict government rules for new vaccine approvals and several product recalls are factors that may limit the global meningococcal vaccines market size over the forecast period. www.marketresearchfuture.com

  3. Meningococcal Vaccines Market Meningococcal Vaccines Market Segmentation The Market Research Future Report provides an inclusive segmental analysis of the global meningococcal vaccines market based on end user and treatment type. Based on treatment type, the global meningococcal vaccines market is segmented into subcapsular vaccine, polysaccharide, and meningococcal conjugate vaccine. Of these, the meningococcal conjugate vaccine will lead the market over the forecast period. Factors propelling the growth of this segment include the high use of this vaccine as it superior compared to polysaccharide immunologic vaccines owing to its ability to elicit long-lasting and greater immunity, protection to infants, and facilitation of immunologic memory. Based on end user, the global meningococcal vaccines market is segmented into research & academic institutes, hospitals and clinics, and others. Of these, the segment of hospitals and clinics will spearhead the market over the forecast period for the rising incidence and prevalence of the disease and increasing application of meningococcal vaccines in hospitals and clinics. This will be followed by research & academic institutes for the increase in R&D in the market. Get Free Sample of Report @ https://www.marketresearchfuture.com/sample_request/8622 www.marketresearchfuture.com

  4. Meningococcal Vaccines Market Meningococcal Vaccines Market – Regional Analysis Based on the region, the global meningococcal vaccines market report covers the recent trends and growth opportunities across Europe, North America, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will lead the market over the forecast period. Factors propelling the market growth include an increase in disease outbreaks, easy availability of products, increasing awareness about the disease, rapid adoption of advanced products, and increasing penetration of new entrants with new technology. The US is the key contributor in the region as it is a leading innovation hub where the leading companies from worldwide conduct R&D activities. Europe is predicted to have a healthy growth over the forecast period followed by the APAC region, which is predicted to grow at a fast pace for the increasing awareness about the disease, improving access to the healthcare system, and the presence of a huge population. Browse Report @ https://www.marketresearchfuture.com/reports/meningococcal-vaccines-market-8622 www.marketresearchfuture.com

  5. Meningococcal Vaccines Market Meningococcal Vaccines Market Competitive Analysis Notable players profiled in the global meningococcal vaccines market report include GlaxoSmithKline, Serum Institute of India Ltd., Biomed Pvt. Ltd., JN-International Medical Corporation, Sanofi S.A., Novartis Pharmaceuticals Canada Inc, Pfizer Inc., and Baxter International, among others. Industry players have incorporated strategies such as mergers & acquisitions, geographical expansions, strategic alliances, contracts, new product development, joint ventures, and collaborations to stay ahead in the competition and also cater to the burgeoning needs of customers. April 2020: The US FDA has approved MenQuadfi meningococcal conjugate vaccine to prevent invasive meningococcal disease in people aged two years and above. This vaccine has tetanus toxoid as protein carriers. Ask Questions To The Experts @ https://www.marketresearchfuture.com/enquiry/8622 www.marketresearchfuture.com

  6. ABOUT US MARKET RESEARCH FUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  7. MARKET RESEARCH FUTURE THANK YOU sales@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related